{{Rsnum
|rsid=1402627
|Gene=DLGAP1
|Chromosome=18
|position=4133739
|Orientation=plus
|GMAF=0.1272
|Gene_s=DLGAP1
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.6 | 32.7 | 2.7
| HCB | 74.3 | 22.8 | 2.9
| JPT | 73.5 | 22.1 | 4.4
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 74.3 | 22.8 | 2.9
| CHD | 66.1 | 31.2 | 2.8
| GIH | 92.1 | 7.9 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 86.2 | 12.1 | 1.7
| MKK | 90.3 | 9.0 | 0.6
| TSI | 60.8 | 36.3 | 2.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1402627
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363833
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1402627
|overall_frequency_n=113
|overall_frequency_d=128
|overall_frequency=0.882812
|n_genomes=52
|n_genomes_annotated=0
|n_haplomes=94
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}